AzTrials
AzTrials

Electroconvulsive Therapy (ECT)PE-ECTNCT07586358

Effect of Psychoeducation on Internalized Stigma and Anxiety in Patients Receiving Electroconvulsive Therapy

A study testing Psychoeducational Programme and Routine Psychiatric Nursing Care in people with Electroconvulsive Therapy (ECT) and Mental Illnesses, run by Konya Necmettin Erbakan Üniversitesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled clinical trial was conducted to evaluate the effect of a psychoeducational programme on internalised stigma and anxiety levels in patients undergoing electroconvulsive therapy (ECT). Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Psychoeducational Programme and Routine Psychiatric Nursing Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Aug 2025to 21 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years
  • Able to read and write in Turkish
  • At least primary school graduate
  • Diagnosed according to DSM-5 criteria with schizophrenia or other psychotic disorders, bipolar disorder, major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder
  • Inpatients in a psychiatric clinic
  • Receiving or scheduled to receive electroconvulsive therapy (ECT)
  • No severe agitation or homicidal risk as determined by the treating psychiatrist
  • Voluntary consent to participate in the study

Who cannot join

  • Diagnosis of organic mental disorders (e.g., dementia, Alzheimer's disease, delirium)
  • Intellectual disability
  • History of alcohol or substance dependence
  • Not completing at least 4 ECT sessions during the treatment process

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Necmettin Erbakan University

    Konya, Meram

Other trials in Turkey (Türkiye)

About this study

Official title: THE EFFECT OF PSYCHOEDUCATION PROGRAM APPLIED TO PATIENTS RECEIVING ELECTROCONVULSIVE THERAPY ON PATIENTS' INTERNALIZED STIGMA AND ANXIETY LEVELS: A RANDOMIZED CONTROLLED STUDY

This randomized controlled clinical trial was conducted to evaluate the effect of a psychoeducational programme on internalised stigma and anxiety levels in patients undergoing electroconvulsive therapy (ECT). The study aimed to determine whether the psychoeducational intervention reduces internalised stigma related to mental illness and improves anxiety outcomes compared to routine nursing care.

The primary questions addressed were:

Read more

Does the psychoeducational programme reduce internalised stigma in patients receiving ECT? Does the intervention decrease state and trait anxiety levels compared to routine care? Researchers compared a psychoeducational intervention group with a control group receiving routine nursing care to assess the effects of the programme on psychological outcomes.

Participants in the intervention group:

Received a six-session psychoeducational programme delivered individually over six weeks Completed pre-test and post-test assessments using standardized measurement tools

Participants in the control group received routine psychiatric nursing care and completed the same assessment measures at equivalent time points.

Being tested
Psychoeducational Programme, Routine Psychiatric Nursing Care
Keywords
Mental Illness, Electroconvulsive Therapy, Internalised Stigma, Anxiety, Psychoeducation, Psychiatric Nursing
Medical subject headings
Mental Disorders, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychoeducational ProgrammeBehavioural

    A structured psychoeducational programme consisting of six individual face-to-face sessions delivered over six weeks by the researcher. The programme aimed to reduce internalised stigma and anxiety in patients undergoing electroconvulsive therapy (ECT) and included education about illness, treatment process, coping strategies, and emotional support.

  • Routine Psychiatric Nursing CareOther

    Standard psychiatric nursing care provided during electroconvulsive therapy (ECT) treatment. No structured psychoeducational programme was applied.

Study groups in NCT07586358
Study groupRoleWhat they receive
Psychoeducation Group (Arm 1)ExperimentalParticipants received a structured psychoeducational programme in addition to routine psychiatric care.
Receives: Behavioral: Psychoeducational Programme
Routine Care Group (Arm 2)Active comparatorParticipants in this arm received routine psychiatric nursing care provided in the inpatient psychiatric clinic without any additional psychoeducational intervention.
Receives: Other: Routine Psychiatric Nursing Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Internalised Stigma Scale for Mental Illness (ISMI)

    Change in internalized stigma levels in patients undergoing electroconvulsive therapy (ECT), measured using the Internalized Stigma of Mental Illness Scale (ISMI). Higher scores indicate higher levels of internalized stigma.

    Measured: Baseline and 6 weeks post-intervention

Secondary outcomes (2)
  1. State Anxiety Score (STAI-State)

    Change in state anxiety levels in patients undergoing electroconvulsive therapy (ECT), measured using the STAI-State subscale. Higher scores indicate higher levels of current anxiety.

    Measured: Baseline and 6 weeks post-intervention

  2. Trait Anxiety Score (STAI-Trait)

    Change in trait anxiety levels in patients undergoing electroconvulsive therapy (ECT), measured using the STAI-Trait subscale. Higher scores indicate general anxiety tendency.

    Measured: Baseline and 6 weeks post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2026
  2. Study start20 Aug 2025
  3. Primary completion20 Dec 2025
  4. Study completion21 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
The type of research is a pre-test and post-test, control group randomised controlled experimental study.
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07586358
Sponsor's protocol ID
NEU-PhDHEM-2026-01
Acronym
PE-ECT
Status last verified
May 2026
First submitted
8 May 2026
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Psychoeducational Programme and Routine Psychiatric Nursing Care in people with Electroconvulsive Therapy (ECT) and Mental Illnesses, run by Konya Necmettin Erbakan Üniversitesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Internalised Stigma Scale for Mental Illness (ISMI) (time frame: Baseline and 6 weeks post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in